LON:CLIN - Clinigen Group Share Price, Forecast & News

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

Clinigen Group announced a dividend on Thursday, September 19th. Investors of record on Thursday, November 7th will be paid a dividend of GBX 4.75 per share on Friday, November 29th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is a boost from Clinigen Group's previous dividend of $1.95. The official announcement can be viewed at this link. View Clinigen Group's Dividend History.

Clinigen Group PLC (LON:CLIN) released its quarterly earnings data on Tuesday, February, 27th. The company reported $21.20 EPS for the quarter, topping the consensus estimate of $20.30 by $0.90. The firm earned $167.80 million during the quarter. View Clinigen Group's Earnings History.

Clinigen Group is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Clinigen Group.

5 analysts have issued 1 year target prices for Clinigen Group's stock. Their forecasts range from GBX 1,035 to GBX 1,640. On average, they anticipate Clinigen Group's share price to reach GBX 1,302 in the next twelve months. This suggests a possible upside of 48.0% from the stock's current price. View Analyst Price Targets for Clinigen Group.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

Headlines about CLIN stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Clinigen Group earned a news impact score of 2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Clinigen Group.

Some companies that are related to Clinigen Group include Envista (NVST), Hikma Pharmaceuticals (HIK), Spark Therapeutics (ONCE), Healthscope (HSO), ConvaTec Group (CTEC), Ansell (ANN), Wound Management Technologies (WNDM), Evotec (EVT), MorphoSys (MOR), BTG (BTGGF), Ablynx (ABLYF), EBOS Group (EBO), MorphoSys (MOR), Cronos Group (CRON) and BTG (BTG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CLIN stock can currently be purchased for approximately GBX 879.50.

Clinigen Group has a market capitalization of £1.17 billion and generates £456.90 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

The official website for Clinigen Group is http://www.clinigengroup.com/.

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.